Insider · CIK 0001508231

Fletcher Robert C.

Reports to the SEC for 2 companies · EXTON, PA

sec.gov

Transactions

Companies

Filings

CIK

0001508231

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-07-21	Aceragen, Inc.Stock Option (Right to Buy)A Award	Sr. VP, Bus. Dev. & Strategy	AAward	+50K sh	—	—	50,000
2020-01-10	Aceragen, Inc.A Award	Sr. VP, Bus. Dev. & Strategy	AAward	+20K sh	—	—	36,485
2020-01-10	Aceragen, Inc.Stock Option (Right to Buy)A Award	Sr. VP, Bus. Dev. & Strategy	AAward	+50K sh	—	—	50,000
2020-01-07	Aceragen, Inc.S Sale	Sr. VP, Bus. Dev. & Strategy	SSale	−1,615 sh	$1.78	−$2,875.346	16,485
2020-01-07	Aceragen, Inc.S Sale	Sr. VP, Bus. Dev. & Strategy	SSale	−1,615 sh	$1.78	−$2,875.346	16,485
2019-07-09	Aceragen, Inc.Stock Option (Right to Buy)A Award	Sr. VP, Bus. Dev. & Strategy	AAward	+45.5K sh	—	—	45,500
2019-01-03	Aceragen, Inc.A Award	Sr. VP, Bus. Dev. & Strategy	AAward	+18.1K sh	—	—	18,100
2019-01-03	Aceragen, Inc.Stock Option (Right to Buy)A Award	Sr. VP, Bus. Dev. & Strategy	AAward	+45.5K sh	—	—	45,500
2018-08-13	Aceragen, Inc.Stock OptionA Award	Sr. VP, Bus. Dev. & Strategy	AAward	+32.5K sh	—	—	32,500
2018-01-03	Aceragen, Inc.Stock OptionA Award	Sr. VP, Bus. Dev. & Strategy	AAward	+270K sh	$2.24	+$605K	270,000
2017-01-03	Aceragen, Inc.Stock OptionA Award	Sr. VP, Bus. Dev. & Strategy	AAward	+185K sh	—	—	185,000
2016-01-06	Aceragen, Inc.Stock OptionA Award	Sr. VP, Bus. Dev. & Strategy	AAward	+185K sh	—	—	185,000
2015-01-26	Aceragen, Inc.Stock OptionA Award	Sr. VP, Bus. Dev. & Strategy	AAward	+600K sh	—	—	600,000
2014-01-24	VIROPHARMA INCU Disposition from Tender	V.P., Business Development	UDisposition from Tender	−37.2K sh	$50.00	−$1.86M	0
2014-01-24	VIROPHARMA INCA Award	V.P., Business Development	AAward	+48.9K sh	—	—	48,878
2014-01-24	VIROPHARMA INCD Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−48.9K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−4,988 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−18K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−12K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−1,222 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−9,578 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−4,265 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−4,380 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−3,000 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−6,000 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−4,000 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−9,000 sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−20.9K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−26.3K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−27.3K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−35.7K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−34.6K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−32.5K sh	—	—	0
2014-01-24	VIROPHARMA INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	V.P., Business Development	DDisposition to Issuer	−5,343 sh	—	—	0
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+7,535 sh	$8.71	+$65.6K	7,764
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−3,288 sh	$49.74	−$164K	4,476
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+7,620 sh	$15.24	+$116K	12,096
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−4,780 sh	$49.74	−$238K	7,316
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+9,000 sh	$13.97	+$126K	16,316
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−5,522 sh	$49.74	−$275K	10,794
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+3,750 sh	$9.96	+$37.4K	14,544
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−1,701 sh	$49.74	−$84.6K	12,843
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+10K sh	$9.99	+$100K	22,855
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−5,486 sh	$49.74	−$273K	17,369
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+6,000 sh	$13.50	+$81K	23,369
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−3,652 sh	$49.74	−$182K	19,717
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+4,000 sh	$5.91	+$23.6K	23,717
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−1,593 sh	$49.74	−$79.2K	22,124
2013-12-18	VIROPHARMA INCM Exercise/Conversion	V.P., Business Development	MExercise/Conversion	+3,000 sh	$8.86	+$26.6K	25,124
2013-12-18	VIROPHARMA INCF Tax Payment	V.P., Business Development	FTax Payment	−1,316 sh	$49.74	−$65.5K	23,808

Recent filings

Accepted (ET)
Jul 234
Fletcher Robert C.0001179110-20-008428
SEC(opens sec.gov)
Jan 144/A
Fletcher Robert C.0001179110-20-000559
SEC(opens sec.gov)
Jan 144
Fletcher Robert C.0001179110-20-000564
SEC(opens sec.gov)
Jan 104
Fletcher Robert C.0001179110-20-000447
SEC(opens sec.gov)
Jul 114
Fletcher Robert C.0001179110-19-008595
SEC(opens sec.gov)
Jan 74
Fletcher Robert C.0001179110-19-000532
SEC(opens sec.gov)
Aug 154
Fletcher Robert C.0001104659-18-052287
SEC(opens sec.gov)
Jan 54
Fletcher Robert C.0001179110-18-000588
SEC(opens sec.gov)
Jan 64
IDERA PHARMACEUTICALS, INC.0001179110-17-000648
SEC(opens sec.gov)
Jan 84
IDERA PHARMACEUTICALS, INC.0001179110-16-017572
SEC(opens sec.gov)
Jan 284
IDERA PHARMACEUTICALS, INC.0001209191-15-007238
SEC(opens sec.gov)
Jan 284
VIROPHARMA INC0001127602-14-003237
SEC(opens sec.gov)

Companies

Address

730 STOCKTON DRIVE

EXTON, PA, 19341